Experimental sepsis in pigs—effects of vasopressin on renal, hepatic, and intestinal dysfunction

References

• Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546–54.
   PubMed Web of Science ®Google Scholar
• Martikainen TJ, Tenhunen JJ, Uusaro A, Ruokonen E. The effects of vasopressin on systemic and splanchnic hemodynamics and metabolism in endotoxin shock. Anesth Analg. 2003;97:1756–63.
   PubMed Web of Science ®Google Scholar
• Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877–87.
   PubMed Web of Science ®Google Scholar
• Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med. 2001;27:1416–21.
   PubMed Web of Science ®Google Scholar
• Sun Q, Dimopoulos G, Nguyen DN, Tu Z, Nagy N, Hoang AD, Low-dose vasopressin in the treatment of septic shock in sheep. Am J Respir Crit Care Med. 2003;168:481–6.
   PubMed Web of Science ®Google Scholar
• Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D’Alessandro D, Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95:1122–5.
   PubMed Web of Science ®Google Scholar
• Moreau R, Lebrec D. The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond. Hepatology. 2006;43:385–94.
   PubMed Web of Science ®Google Scholar
• Rehberg S, Ertmer C, Vincent JL, Spiegel HU, Köhler G, Erren M, Effects of combined arginine vasopressin and levosimendan on organ function in ovine septic shock. Crit Care Med. 2010;38:2016–23.
   PubMed Web of Science ®Google Scholar
• Pastores SM, Katz DP, Kvetan V. Splanchnic ischemia and gut mucosal injury in sepsis and the multiple organ dysfunction syndrome. Am J Gastroenterol. 1996;91:1697–710.
   PubMed Web of Science ®Google Scholar
• Hiltebrand LB, Krejci V, Jakob SM, Takala J, Sigurdsson GH. Effects of vasopressin on microcirculatory blood flow in the gastrointestinal tract in anesthetized pigs in septic shock. Anesthesiology. 2007;106:1156–67.
   PubMed Web of Science ®Google Scholar
• Simon F, Giudici R, Scheuerle A, Gröger M, Asfar P, Vogt JA, Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial. Crit Care. 2009;13:R113.
   PubMed Web of Science ®Google Scholar
• van der Poll T, van Deventer SJ. Cytokines and anticytokines in the pathogenesis of sepsis. Infect Dis Clin North Am. 1999;13:413–26.
   PubMed Web of Science ®Google Scholar
• Doig CJ, Sutherland LR, Sandham JD, Fick GH, Verhoef M, Meddings JB. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med. 1998;158:444–51.
   PubMed Web of Science ®Google Scholar
• Pritts T, Hungness E, Wang Q, Robb B, Hershko D, Hasselgren PO. Mucosal and enterocyte IL-6 production during sepsis and endotoxemia—role of transcription factors and regulation by the stress response. Am J Surg. 2002;183:372–83.
   PubMed Web of Science ®Google Scholar
• Russell JA, Walley KR. Vasopressin and its immune effects in septic shock. J Innate Immun. 2010;2:446–60.
   PubMed Web of Science ®Google Scholar
• Han X, Fink MP, Yang R, Delude RL. Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotoxemic mice. Shock. 2004;21:261–70.
   PubMed Web of Science ®Google Scholar
• Westphal M, Rehberg S, Maybauer MO, Maybauer DM, Enkhbaatar P, Westphal-Varghese BB, Cardiopulmonary effects of low-dose arginine vasopressin in ovine acute lung injury. Crit Care Med. 2011;39:357–63.
   PubMed Web of Science ®Google Scholar
• Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med. 2004;10:1216–21.
   PubMed Web of Science ®Google Scholar
• Albert M, Losser MR, Hayon D, Faivre V, Payen D. Systemic and renal macro- and microcirculatory responses to arginine vasopressin in endotoxic rabbits. Crit Care Med. 2004;32:1891–8.
   PubMed Web of Science ®Google Scholar
• Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA 3rd. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med. 2001;29:487–93.
   PubMed Web of Science ®Google Scholar
• Guzman JA, Rosado AE, Kruse JA. Vasopressin vs norepinephrine in endotoxic shock: systemic, renal, and splanchnic hemodynamic and oxygen transport effects. J Appl Physiol. 2003;95:803–9.
   PubMed Web of Science ®Google Scholar
• Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. 2004;351:159–69.
   PubMed Web of Science ®Google Scholar
• Mikkelsen ME, Miltiades AN, Gaieski DF, Goyal M, Fuchs BD, Shah CV, Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med. 2009;37:1670–7.
   PubMed Web of Science ®Google Scholar
• Dünser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation. 2003;107:2313–19.
   PubMed Web of Science ®Google Scholar
• van Haren FM, Rozendaal FW, van der Hoeven JG. The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest. 2003;124:2256–60.
   PubMed Web of Science ®Google Scholar